Patents by Inventor Celso Vataru Nakamura

Celso Vataru Nakamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ascorbic acid and quinone compounds in combination with an antiparasitic agent for treating a parasitic disease
    Patent number: 11872233
    Abstract: Provided herein is a method of treating, preventing, or alleviating one or more symptoms of Chagas disease in a subject, comprising administering to the subject: (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof; and (iii) an antiparasitic agent.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: January 16, 2024
    Assignee: IC-MedTech Corp.
    Inventors: Sueli de Oliveira Silva Lautenschlager, Vania Cristina Desoti, Celso Vataru Nakamura, Valdecir Farias Ximenes
  • ASCORBIC ACID AND QUINONE COMPOUNDS IN COMBINATION WITH AN ANTIPARASITIC AGENT FOR TREATING A PARASITIC DISEASE
    Publication number: 20210361666
    Abstract: Provided herein is a method of treating, preventing, or alleviating one or more symptoms of Chagas disease in a subject, comprising administering to the subject: (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof; and (iii) an antiparasitic agent.
    Type: Application
    Filed: June 5, 2019
    Publication date: November 25, 2021
    Inventors: Sueli de Oliveira Silva Lautenschlager, Vania Cristina Desoti, Celso Vataru Nakamura, Valdecir Farias Ximenes
  • ASCORBIC ACID AND QUINONE COMPOUNDS FOR TREATING CHAGAS DISEASE
    Publication number: 20190343794
    Abstract: Provided herein is a method of treating, preventing, or alleviating one or more symptoms of Chagas disease in a subject, comprising administering to the subject (i) ascorbic acid, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof; and (ii) a quinone compound, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof.
    Type: Application
    Filed: December 5, 2017
    Publication date: November 14, 2019
    Inventors: Sueli de Oliveira Silva Lautenschlager, Vânia Cristina Desoti, Celso Vataru Nakamura, Valdecir Farias Ximenes